Search Results 171-180 of 19696 for Receptor
A member of the nuclear medicine therapy team talks with a woman before she begins intravenous peptide receptor radionuclide therapy (PRRT). This type of ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study. Cancer. T-cell receptor diversity may be key to treatment of ...
Receptor tyrosine kinase genes regulate essential biological processes in humans, including embryogenesis, adult tissue homeostasis and metabolism. These genes ...
Other blood pressure medicines include beta blockers, angiotensin-converting enzyme inhibitors, also called ACE inhibitors, and angiotensin 2 receptor blockers.
... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...
Famotidine belongs to the group of medicines known as histamine H2-receptor antagonists or H2-blockers. It works by decreasing the amount of acid produced ...
Olmesartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes the blood vessels to tighten. As a result ...
Mayo Clinic's T Cell Engineering Lab of Saad J. Kenderian, M.B., Ch.B., studies engineered virus and cell, chimeric antigen receptor (CAR)-T cell therapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.